Literature DB >> 8662957

The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells.

S M Wood1, J M Gleadle, C W Pugh, O Hankinson, P J Ratcliffe.   

Abstract

Hypoxia-inducible factor-1 (HIF-1), a DNA-binding complex implicated in the regulation of gene expression by oxygen, has been shown to consist of a heterodimer of two basic helix-loop-helix Per-AHR-ARNT-Sim (PAS) proteins, HIF-1alpha, and HIF-1beta. One partner, HIF-1beta, had been recognized previously as the aryl hydrocarbon receptor nuclear translocator (ARNT), an essential component of the xenobiotic response. In the present work, ARNT-deficient mutant cells, originally derived from the mouse hepatoma line Hepa1c1c7, have been used to analyze the role of ARNT/HIF-1beta in oxygen-regulated gene expression. Two stimuli were examined: hypoxia itself and desferrioxamine, an iron-chelating agent that also activates HIF-1. Induction of the DNA binding and transcriptional activity of HIF-1 was absent in the mutant cells, indicating an essential role for ARNT/HIF-1beta. Analysis of deleted ARNT/HIF-1beta genes indicated that the basic, helix-loop-helix, and PAS domains, but not the amino or carboxyl termini, were necessary for function in the response to hypoxia. Comparison of gene expression in wild type and mutant cells demonstrated the critical importance of ARNT/HIF-1beta in the hypoxic induction of a wide variety of genes. Nevertheless, for some genes a reduced response to hypoxia and desferrioxamine persisted in these mutant cells, clearly distinguishing ARNT/HIF-1beta-dependent and ARNT/HIF-1beta-independent mechanisms of gene activation by both these stimuli.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662957     DOI: 10.1074/jbc.271.25.15117

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2.

Authors:  Natalie J German; Haejin Yoon; Rushdia Z Yusuf; J Patrick Murphy; Lydia W S Finley; Gaëlle Laurent; Wilhelm Haas; F Kyle Satterstrom; Jlenia Guarnerio; Elma Zaganjor; Daniel Santos; Pier Paolo Pandolfi; Andrew H Beck; Steven P Gygi; David T Scadden; William G Kaelin; Marcia C Haigis
Journal:  Mol Cell       Date:  2016-09-15       Impact factor: 17.970

2.  RGS5, a hypoxia-inducible apoptotic stimulator in endothelial cells.

Authors:  Yi Jin; Xiaojin An; Zelian Ye; Brittany Cully; Jiaping Wu; Jian Li
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

3.  Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.

Authors:  Peter Büchler; Howard A Reber; James S Tomlinson; Oliver Hankinson; Georgis Kallifatidis; Helmut Friess; Ingrid Herr; Oscar J Hines
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

4.  Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines.

Authors:  Medhi Wangpaichitr; Niramol Savaraj; Johnathan Maher; Metin Kurtoglu; Theodore J Lampidis
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

Review 5.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

Review 6.  Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.

Authors:  Honglian Shi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 7.  Hypoxia regulates the hematopoietic stem cell niche.

Authors:  Takayuki Morikawa; Keiyo Takubo
Journal:  Pflugers Arch       Date:  2015-10-21       Impact factor: 3.657

8.  Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1.

Authors:  Nuria Pescador; Diego Villar; Daniel Cifuentes; Mar Garcia-Rocha; Amaya Ortiz-Barahona; Silvia Vazquez; Angel Ordoñez; Yolanda Cuevas; David Saez-Morales; Maria Laura Garcia-Bermejo; Manuel O Landazuri; Joan Guinovart; Luis del Peso
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

Review 9.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

10.  Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction.

Authors:  Amaya Ortiz-Barahona; Diego Villar; Nuria Pescador; Jorge Amigo; Luis del Peso
Journal:  Nucleic Acids Res       Date:  2010-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.